SG11202007561TA - Treatment of post-operative joint pain with polysulfated polysaccharides - Google Patents
Treatment of post-operative joint pain with polysulfated polysaccharidesInfo
- Publication number
- SG11202007561TA SG11202007561TA SG11202007561TA SG11202007561TA SG11202007561TA SG 11202007561T A SG11202007561T A SG 11202007561TA SG 11202007561T A SG11202007561T A SG 11202007561TA SG 11202007561T A SG11202007561T A SG 11202007561TA SG 11202007561T A SG11202007561T A SG 11202007561TA
- Authority
- SG
- Singapore
- Prior art keywords
- post
- treatment
- joint pain
- polysulfated polysaccharides
- operative joint
- Prior art date
Links
- 208000006820 Arthralgia Diseases 0.000 title 1
- 150000004676 glycans Chemical class 0.000 title 1
- 229920001282 polysaccharide Polymers 0.000 title 1
- 239000005017 polysaccharide Substances 0.000 title 1
- 230000002980 postoperative effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/417—Evaluating particular organs or parts of the immune or lymphatic systems the bone marrow
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- High Energy & Nuclear Physics (AREA)
- Radiology & Medical Imaging (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018900650A AU2018900650A0 (en) | 2018-02-28 | Treatment of post-operative joint pain with polysulfated polysaccharides | |
| PCT/AU2019/050163 WO2019165498A1 (en) | 2018-02-28 | 2019-02-27 | Treatment of post-operative joint pain with polysulfated polysaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202007561TA true SG11202007561TA (en) | 2020-09-29 |
Family
ID=67804786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202007561TA SG11202007561TA (en) | 2018-02-28 | 2019-02-27 | Treatment of post-operative joint pain with polysulfated polysaccharides |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11701382B2 (en) |
| EP (1) | EP3758717A4 (en) |
| JP (1) | JP7391858B2 (en) |
| KR (1) | KR20210003087A (en) |
| CN (1) | CN112203665A (en) |
| AU (1) | AU2019226627B2 (en) |
| CA (1) | CA3091632A1 (en) |
| NZ (1) | NZ768328A (en) |
| SG (1) | SG11202007561TA (en) |
| WO (1) | WO2019165498A1 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6924273B2 (en) | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
| US6593310B1 (en) | 2000-11-21 | 2003-07-15 | Arthropharm Pty. Ltd. | Treatment of osteoporosis |
| US20080076723A1 (en) | 2006-09-27 | 2008-03-27 | Sylvan Pharmaceuticals Pty Ltd. | Inhibition of cathepsin K activity and the treatment and prevention of disease |
| CA2689027C (en) | 2007-05-31 | 2016-07-19 | Deirdre Roma Coombe | Sulphated xylans for treatment or prophylaxis of respiratory diseases |
| TWI520740B (en) | 2011-02-02 | 2016-02-11 | 模範健康科技私人企業有限公司 | Treatment of bone marrow edema (oedema) with polysulfated polysaccharides |
| AU2015218642A1 (en) * | 2014-02-24 | 2016-10-06 | Michael Goldberg | Compositions of pentosan polysulfate salts for oral administration and methods of use |
| US9486476B2 (en) | 2014-08-05 | 2016-11-08 | Natures Products, Inc | Fast acting joint relief formulations |
| CN111417399A (en) | 2017-08-04 | 2020-07-14 | 帕拉迪生物制药有限公司 | Polysulfated polysaccharides for the treatment of myelopathy |
-
2019
- 2019-02-27 SG SG11202007561TA patent/SG11202007561TA/en unknown
- 2019-02-27 NZ NZ768328A patent/NZ768328A/en unknown
- 2019-02-27 CA CA3091632A patent/CA3091632A1/en active Pending
- 2019-02-27 US US16/976,671 patent/US11701382B2/en active Active
- 2019-02-27 AU AU2019226627A patent/AU2019226627B2/en active Active
- 2019-02-27 KR KR1020207025964A patent/KR20210003087A/en unknown
- 2019-02-27 JP JP2020545141A patent/JP7391858B2/en active Active
- 2019-02-27 CN CN201980016173.3A patent/CN112203665A/en active Pending
- 2019-02-27 EP EP19759993.9A patent/EP3758717A4/en active Pending
- 2019-02-27 WO PCT/AU2019/050163 patent/WO2019165498A1/en active Search and Examination
-
2023
- 2023-06-01 US US18/204,492 patent/US20230381219A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN112203665A (en) | 2021-01-08 |
| JP7391858B2 (en) | 2023-12-05 |
| AU2019226627B2 (en) | 2021-03-04 |
| NZ768328A (en) | 2022-09-30 |
| AU2019226627A1 (en) | 2020-10-15 |
| US20230381219A1 (en) | 2023-11-30 |
| WO2019165498A1 (en) | 2019-09-06 |
| EP3758717A4 (en) | 2021-11-24 |
| US20210000862A1 (en) | 2021-01-07 |
| KR20210003087A (en) | 2021-01-11 |
| EP3758717A1 (en) | 2021-01-06 |
| JP2021514988A (en) | 2021-06-17 |
| CA3091632A1 (en) | 2019-09-06 |
| US11701382B2 (en) | 2023-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202010730SA (en) | Use of glycosidases in the production of oligosaccharides | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| IL279180A (en) | Methods of treating conditions related to the s1p1 receptor | |
| IL280172A (en) | Highly sulfated fucans for the treatment of fibrous adhesions | |
| IL272937A (en) | Compositions and methods for the treatment of fibrotic diseases | |
| SG11202011590YA (en) | Additive manufacture of complex implantable living devices | |
| SG11202103319SA (en) | Treatment of pain with polysulfated polysaccharides | |
| HK1249846A1 (en) | Apparatus for transmission of subsonic sound waves to the human body | |
| EP3728279A4 (en) | Glucosamine derivatives for the prevention or treatment of joint disorders | |
| EP3727361A4 (en) | Treatment of pain and/or pain related symptoms associated with dysmenorrhea | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| IL275349A (en) | Use of hm4di in the treatment of seizure disorders | |
| GB201710822D0 (en) | Methods and medical uses relating to the treatment of hypoglycaemia | |
| EP3661524A4 (en) | Treatment of bone marrow pathologies with polysulfated polysaccharides | |
| SG11202007561TA (en) | Treatment of post-operative joint pain with polysulfated polysaccharides | |
| FI4062916T3 (en) | Treating fabry patients having certain mutations | |
| AU2018900650A0 (en) | Treatment of post-operative joint pain with polysulfated polysaccharides | |
| IL275247A (en) | Glucosamine derivatives for the prevention or treatment of joint disorders | |
| AU2018903820A0 (en) | Treatment of pain with polysulfated polysaccharides | |
| IL274838A (en) | Use of mir101 or mir128 in the treatment of seizure disorders | |
| GB2534955B (en) | Flexible pipe connector and method of using the same | |
| AU2019903556A0 (en) | Treatment of pain with polysulfated polysaccharides | |
| AU2019900326A0 (en) | Treatment of pain with polysulfated polysaccharides | |
| EP3691644A4 (en) | Methods of treating acute or chronic pain | |
| ZA201904326B (en) | Treatment of joint pain |